Pharmaceutical Companies

3,872 pharmaceutical companies, compiled from public registers and the BioBridgeX marketplace. Open any company for its headquarters, FDA-registered sites and public filings.

Pharmaceutical Companies

3,872 companies, best-documented first.

Show the first companies

1. GENELUX CorpNasdaq: GNLXWestlake Village, California, United States
2. Inovio Pharmaceuticals, Inc.Nasdaq: INOPlymouth Meeting, Pennsylvania, United States
3. Keros Therapeutics, Inc.Nasdaq: KROSLexington, Massachusetts, United States
4. Minerva Neurosciences, Inc.Nasdaq: NERVBurlington, Massachusetts, United States
5. Satellos Bioscience Inc.Nasdaq: MSLEMarkham, Ontario, Canada
6. Stoke Therapeutics, Inc.Nasdaq: STOKBedford, Massachusetts, United States
7. Tempest Therapeutics, Inc.Nasdaq: TPSTBrisbane, California, United States
8. Tyra Biosciences, Inc.Nasdaq: TYRACarlsbad, California, United States
9. Werewolf Therapeutics, Inc.Nasdaq: HOWLWaltham, Massachusetts, United States
10. Zevra Therapeutics, Inc.Nasdaq: ZVRABoston, Massachusetts, United States
11. IPI Legacy Liquidation CoSeattle, Washington, United States
12. Tiziana Life Sciences LtdNasdaq: TLSALondon, England, United Kingdom
13. Bio-Path Holdings, Inc.OTC: BPTHBellaire, Texas, United States
14. Evolus, Inc.Nasdaq: EOLSNewport Beach, California, United States
15. NeuroSense Therapeutics Ltd.Nasdaq: NRSNHerzliya, Tel Aviv, Israel
16. Aimmune Therapeutics, Inc.Brisbane, California, United States
17. Ironwood Pharmaceuticals IncNasdaq: IRWDBoston, Massachusetts, United States
18. Acurx Pharmaceuticals, Inc.Nasdaq: ACXPStaten Island, New York, United States
19. Corvus Pharmaceuticals, Inc.Nasdaq: CRVSSouth San Francisco, California, United States
20. Edesa Biotech, Inc.Nasdaq: EDSAMarkham, Ontario, Canada

Other company types

Outsourcing a study or a manufacturing run?

Describe the work once and compare quotes from CROs and CDMOs on BioBridgeX. Free for buyers.

Counts include published company profiles only and update daily. Data licences

Is a company missing or wrong? Tell us.